L & S Advisors Inc Seagen Inc. Transaction History

L & S Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $4.2 Million - $6.92 Million	38,571 New	38,571 $6.83 Million
Q1 2022 May 11, 2022	SELL	$119.61 - $157.85 $549,009 - $724,531	-4,590 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$142.57 - $190.86 $425,999 - $570,289	2,988 Added 186.52%	4,590 $710,000
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $67,540 - $80,550	-500 Reduced 23.79%	1,602 $253,000
Q1 2021 May 10, 2021	SELL	$137.51 - $190.8 $1.24 Million - $1.72 Million	-9,010 Reduced 81.08%	2,102 $292,000
Q4 2020 Feb 16, 2021	SELL	$164.63 - $211.93 $1.57 Million - $2.02 Million	-9,552 Reduced 46.23%	11,112 $1.95 Million
Q3 2020 Nov 13, 2020	BUY	$145.95 - $195.69 $3.02 Million - $4.04 Million	20,664 New	20,664 $4.04 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.